INTERNATIONAL PATENT: XGENE PHARMACEUTICAL INC., XU, FENG FILES APPLICATION FOR "NAPROXEN/PREGABALIN CONJUGATE DOSING REGIMEN"

GENEVA, Feb. 18 -- XGENE PHARMACEUTICAL INC. (Offshore Incorporations (Cayman) LimitedFloor 4 Willow House, Cricket Square P.O. Box 2804Grand Cayman, KY1-1112), XU, Feng (Offshore Incorporations (Cayman) LimitedFloor 4 Willow House, Cricket Square P.O. Box 2804Grand Cayman, KY1-1112) filed a patent application (PCT/US2025/040285) for "NAPROXEN/PREGABALIN CONJUGATE DOSING REGIMEN" on Aug 01, 2025. With publication no. WO/2026/035552, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JIANG, Guang Liang (Offshore Incorporation...